Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

45
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
45
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

17
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
17
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pixel-Level RGBT Fusion Tracking via Heterogeneous Multi-Expert Distillation and Decoupled Representation Learning.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

Exploration of the Clinical Assessment and Prognostic Value of Society for Cardiovascular Angiography and Intervention Shock Staging in Patients With Acute Myocardial Infarction and Cardiogenic Shock on Veno-arterial Extracorporeal Membrane Oxygenation Support.

Reviews in cardiovascular medicine·2026
Same author

Unveiling the Power of Multi-Modal Template Update in RGBT Tracking.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

ECMO management in cardiogenic shock-specialized versus non-cardiogenic shock-specialized centers: a registry-based analysis.

BMC anesthesiology·2025
Same author

Clinical study of area-decreasing technique and conventional post-closure technique for V-A ECMO weaning application: study protocol of a randomised controlled trial.

BMJ open·2025
Same author

AFTER: Attention-Based Fusion Router for RGBT Tracking.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2025
Same journal

Tailoring Antiplatelet Therapy Duration After PFO Closure: Insights From the PROLONG Registry.

JACC. Advances·2026
Same journal

Meteorological and Environmental Factors Associated With Sudden Cardiac Arrest During Marathons in Japan.

JACC. Advances·2026
Same journal

Clinical Patterns and Appropriateness of Apixaban Dosing in Patients With Atrial Fibrillation.

JACC. Advances·2026
Same journal

Outpatient Point-of-Care Cardiopulmonary Exercise Testing in Chronic Thromboembolic Pulmonary Disease: A Single-Center Experience.

JACC. Advances·2026
Same journal

Frailty Severity Outcomes After Left Atrial Appendage Occlusion.

JACC. Advances·2026
Same journal

Occupational Pelvic and Chest-Level Radiation Exposure Among Interventional Echocardiographers During Percutaneous Structural Heart Interventions.

JACC. Advances·2026
See all related articles

Related Experiment Video

Updated: Sep 10, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K

Prophylactic VA-ECMO During Complex High-Risk PCI: A Randomized Controlled Trial.

Chenliang Pan1, Youqi Zhu1, Jing Zhao1

  • 1The First School of Clinical Medicine of Lanzhou University, Lanzhou, China; Heart Center, The First Hospital of Lanzhou University, Lanzhou, China; Gansu Province Clinical Research Center for Cardiovascular Diseases, Lanzhou, China.

JACC. Advances
|August 22, 2025
PubMed
Summary
This summary is machine-generated.

Prophylactic venoarterial extracorporeal membrane oxygenation (VA-ECMO) during high-risk percutaneous coronary intervention (PCI) significantly reduced life-threatening complications and improved outcomes. This approach offers a safer strategy for complex PCI patients.

Keywords:
complex high-risk coronary artery interventionefficacymajor adverse cardiovascular and cerebrovascular eventssafetyvenoarterial extracorporeal membrane oxygenation

More Related Videos

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

430
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

Related Experiment Videos

Last Updated: Sep 10, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

430
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Critical Care Medicine

Background:

  • Limited evidence exists for prophylactic venoarterial extracorporeal membrane oxygenation (VA-ECMO) in high-risk percutaneous coronary intervention (PCI).
  • Patients with complex coronary lesions often face significant procedural risks.

Purpose of the Study:

  • To evaluate the safety and effectiveness of prophylactic VA-ECMO during elective PCI.
  • To compare complication rates and SYNTAX score reduction in patients undergoing PCI with or without prophylactic VA-ECMO.

Main Methods:

  • A single-center randomized trial involving 70 patients with high-risk coronary lesions (SYNTAX score ≥33) who declined bypass surgery.
  • Patients were assigned to either prophylactic VA-ECMO (n=34) or a control group (n=36) before PCI.
  • Primary endpoints included complication rates and SYNTAX score reduction post-PCI.

Main Results:

  • The prophylactic VA-ECMO group experienced significantly lower rates of life-threatening complications (0% vs. 19.4%, P=0.01).
  • Emergency VA-ECMO was needed in 19.4% of the control group.
  • The VA-ECMO group demonstrated a greater absolute reduction in SYNTAX scores (27.2 vs. 22.5, P=0.04).

Conclusions:

  • Prophylactic VA-ECMO is associated with reduced life-threatening complications during high-risk PCI.
  • This strategy also leads to a more significant reduction in coronary lesion complexity as measured by SYNTAX scores.
  • Further large-scale studies are warranted to confirm these findings and optimize management strategies.